Analyzing cytotoxic effects of selected isothiazol-3-one biocides using the toxic ratio concept and

Jürgen Arning1, Marianne Matzke, Stefan Stolte

  • 1Department 3 Sustainability in Chemistry, UFT-Centre for Environmental Research and Sustainable Technology, University of Bremen, Leobener Strasse, D-28359 Bremen, Germany. jarning@unibremen.de

Insights

This study shows that highly hydrophobic biocides can mask specific toxic actions, potentially leading to underestimation of risks in hazard assessments. Careful analysis is needed to distinguish baseline toxicity from reactivity-driven effects.

Area of Science:

  • Environmental Toxicology
  • Chemical Risk Assessment
  • Biocide Ecotoxicology

Background:

  • Baseline toxicity is a general mode of toxic action, often related to hydrophobicity.
  • Reactive xenobiotics can exhibit specific toxic mechanisms beyond baseline effects.
  • Hydrophobic substances may obscure specific toxicities in standard assays.

Purpose of the Study:

  • To differentiate baseline toxicity from specific modes of toxic action in isothiazolones.
  • To investigate pitfalls in assessing hydrophobic and reactive substances.
  • To evaluate the cytotoxic effects of four isothiazolones across different test systems.

Main Methods:

  • Cytotoxicity testing of N-methylisothiazol-3-one (MIT), 5-chloro-N-methylisothiazol-3-one (CIT), N-octylisothiazol-3-one (OIT), and 4,5-dichloro-N-octylisothiazol-3-one (DCOIT).
  • Utilized human hepatoblastoma cell line (Hep G2), marine bacterium (Vibrio fischeri), and green alga (Scenedesmus vacuolatus).
  • Applied toxic ratio concept and measured cellular glutathione depletion.

Main Results:

  • Consistent toxicity patterns observed across all three test systems.
  • Chlorinated isothiazolones (CIT, DCOIT) and OIT were more toxic than MIT.
  • MIT and CIT showed excess toxicity attributed to thiol reactivity, while OIT and DCOIT toxicity related to hydrophobicity.
  • DCOIT incubation led to significant glutathione depletion.

Conclusions:

  • Hydrophobicity can mask specific toxic actions of reactive chemicals, complicating hazard assessment.
  • Baseline toxicity assessments may overlook significant, less reversible effects of reactive compounds.
  • Consideration of both hydrophobicity and reactivity is crucial for accurate chemical hazard evaluation.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...